Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Sertraline, an antidepressant, may rarely cause hair loss.

Stress worsens hair loss in androgenetic alopecia.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

The YH complex, made from Astragalus membranaceus and Cinnamomum cassia, may help treat hair loss by promoting hair growth and follicle development.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Sertraline, an antidepressant, may cause hair loss in rare cases.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Accurate diagnosis and treatment of skin and hair disorders are crucial, with growing focus on hair loss treatments like topical minoxidil.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

The document summarizes skin and immune system disease findings, especially related to AIDS, from the 1980s.

L'Oréal's research and workshops have advanced understanding and tailored cosmetics for African hair and skin.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Polymeric nanoparticles show promise for treating skin diseases.

Patients on long-term hemodialysis often have skin problems related to their treatment.